Insider Trades28 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2026 | Sell | INO | Laurent Humeau | Chief Scientific Officer | 2,163 | $1.23 | $129.2M | -55.67% | +121.95% | $2.7K | -1.76% | — | — |
| May 20, 2026 | Sell | INO | Michael John Sumner | Chief Medical Officer | 2,693 | $1.23 | $129.2M | -55.67% | +121.95% | $3.3K | -1.82% | — | — |
| May 20, 2026 | Sell | INO | Peter Kies | CFO | 4,688 | $1.23 | $129.2M | -55.67% | +121.95% | $5.8K | -3.42% | — | — |
| May 20, 2026 | Sell | INO | Jacqueline Elizabeth Shea | Chief Executive Officer | 12,306 | $1.23 | $129.2M | -55.67% | +121.95% | $15.1K | -3.05% | — | — |
| May 15, 2026 | Sell | INO | Michael John Sumner | Chief Medical Officer | 680 | $1.30 | $129.2M | -55.67% | +121.95% | $884 | -1.89% | — | — |
| May 15, 2026 | Sell | INO | Laurent Humeau | Chief Scientific Officer | 1,712 | $1.30 | $129.2M | -55.67% | +121.95% | $2.2K | -3.83% | — | — |
| May 15, 2026 | Sell | INO | Peter Kies | CFO | 2,571 | $1.30 | $129.2M | -55.67% | +121.95% | $3.3K | -6.21% | — | — |
| May 15, 2026 | Sell | INO | Jacqueline Elizabeth Shea | Chief Executive Officer | 7,717 | $1.30 | $129.2M | -55.67% | +121.95% | $10.0K | -7.51% | — | — |
| Mar 31, 2026 | Sell | INO | Michael John Sumner | Chief Medical Officer | 1,223 | $1.74 | $129.2M | -55.67% | +121.95% | $2.1K | -3.51% | — | — |
| Feb 26, 2026 | Sell | INO | Michael John Sumner | Chief Medical Officer | 3,903 | $1.79 | $129.2M | -55.67% | +121.95% | $7.0K | -6.24% | — | — |
| Feb 26, 2026 | Sell | INO | Laurent Humeau | Chief Scientific Officer | 5,098 | $1.79 | $129.2M | -55.67% | +121.95% | $9.1K | -5.08% | — | — |
| Feb 26, 2026 | Sell | INO | Peter Kies | CFO | 9,259 | $1.79 | $129.2M | -55.67% | +121.95% | $16.6K | -8.86% | — | — |
| Feb 26, 2026 | Sell | INO | Jacqueline Elizabeth Shea | Chief Executive Officer | 21,714 | $1.79 | $129.2M | -55.67% | +121.95% | $38.9K | -8.60% | — | — |
| May 15, 2025 | Sell | INO | Michael John Sumner | Chief Medical Officer | 680 | $1.95 | $129.2M | -55.67% | +121.95% | $1.3K | -3.78% | — | — |
| May 15, 2025 | Sell | INO | Laurent Humeau | Chief Scientific Officer | 1,708 | $1.95 | $129.2M | -55.67% | +121.95% | $3.3K | -4.37% | — | — |
| May 15, 2025 | Sell | INO | Peter Kies | CFO | 2,566 | $1.95 | $129.2M | -55.67% | +121.95% | $5.0K | -6.83% | — | — |
| May 15, 2025 | Sell | INO | Jacqueline Elizabeth Shea | Chief Executive Officer | 7,717 | $1.95 | $129.2M | -55.67% | +121.95% | $15.0K | -9.06% | — | — |
| May 10, 2025 | Sell | INO | Jacqueline Elizabeth Shea | Chief Executive Officer | 2,392 | $1.80 | $129.2M | -55.67% | +121.95% | $4.3K | -4.60% | — | — |
| Feb 26, 2025 | Sell | INO | Laurent Humeau | Chief Scientific Officer | 3,643 | $1.98 | $129.2M | -55.67% | +121.95% | $7.2K | -3.05% | — | — |
| Feb 26, 2025 | Sell | INO | Peter Kies | CFO | 5,322 | $1.98 | $129.2M | -55.67% | +121.95% | $10.5K | -3.79% | — | — |
| Feb 26, 2025 | Sell | INO | Jacqueline Elizabeth Shea | Chief Executive Officer | 11,581 | $1.98 | $129.2M | -55.67% | +121.95% | $22.9K | -3.58% | — | — |
| May 15, 2024 | Sell | INO | Laurent Humeau | Chief Scientific Officer | 1,703 | $13.07 | $129.2M | -55.67% | +121.95% | $22.3K | -4.79% | — | — |
| May 15, 2024 | Sell | INO | Peter Kies | CFO | 2,562 | $13.07 | $129.2M | -55.67% | +121.95% | $33.5K | -7.02% | — | — |
| May 15, 2024 | Sell | INO | Jacqueline Elizabeth Shea | Chief Executive Officer | 7,718 | $13.07 | $129.2M | -55.67% | +121.95% | $100.9K | -10.04% | — | — |
| May 10, 2024 | Sell | INO | Jacqueline Elizabeth Shea | Chief Executive Officer | 2,392 | $10.65 | $129.2M | -55.67% | +121.95% | $25.5K | -7.59% | — | — |
| Feb 26, 2024 | Sell | INO | Laurent Humeau | Chief Scientific Officer | 2,351 | $8.16 | $129.2M | -55.67% | +121.95% | $19.2K | -2.93% | — | — |
| Feb 26, 2024 | Sell | INO | Peter Kies | CFO | 3,466 | $8.16 | $129.2M | -55.67% | +121.95% | $28.3K | -4.13% | — | — |
| Feb 26, 2024 | Sell | INO | Jacqueline Elizabeth Shea | Chief Executive Officer | 3,728 | $8.16 | $129.2M | -55.67% | +121.95% | $30.4K | -2.15% | — | — |